Grand Pharma (00512) Six Products Successfully Included in the 2026 National Reimbursement Drug List, Commercial Insurance Innovative Drug List, and Industry Supporting List

Zhitong Finance APP news, Grand Pharma (00512) announced that recently, a total of six products of the Group were successfully included in the "National Basic Medical Insurance, Maternity Insurance and Work Injury Insurance Drug Catalog (2026)" and the "Commercial Health Insurance Innovative Drug Catalog (2026)" issued by the National Healthcare Security Administration of the People's Republic of China (NHSA), the "Recommended List of Commercial Health Insurance Drug Coverage (First Edition)" issued by the Insurance Association of China, or the "Drugs Involved in the Calculation of Commercial Health Insurance Coverage Costs" issued by the China Association of Actuaries.